title: Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
authors: Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. cpic@pharmgkb.org
authors: M V
authors: MV
authors: Relling
authors: E E
authors: EE
authors: Gardner
authors: W J
authors: WJ
authors: Sandborn
authors: K
authors: K
authors: Schmiegelow
authors: C-H
authors: CH
authors: Pui
authors: S W
authors: SW
authors: Yee
authors: C M
authors: CM
authors: Stein
authors: M
authors: M
authors: Carrillo
authors: W E
authors: WE
authors: Evans
authors: J K
authors: JK
authors: Hicks
authors: M
authors: M
authors: Schwab
authors: T E
authors: TE
authors: Klein
mesh_terms: D000963:Antimetabolites / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage*; D005838:Genotype; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage*; D008780:Methyltransferases / Q000235:genetics*
chemical_list: D000963:Antimetabolites; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine